Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristin N. Voorhees
Observed names:
K. Voorhees,
Kristin Voorhees,
Voorhees, Kristin
Institution:
Ultragenyx Pharmaceutical (United States)
Observed institutions:
Ultragenyx Pharmaceutical (United States),
Beyond Celiac,
University of Colorado Anschutz,
University of Colorado Denver
OpenAlex ID:
A5082515031
Outcome measures in coeliac disease trials: the Tampere recommendations
2018
·
Jonas F Ludvigsson
, Carolina Ciacci
, et al.
·
Gut
·
100
PDF
Self-reported dietary adherence, disease-specific symptoms, and quality of life are associated with healthcare provider follow-up in celiac disease
2017
·
Jacob J. Hughey
, Bonnie K. Ray
, et al.
·
BMC Gastroenterology
·
45
PDF
Underinsurance in Primary Care: A Report from the State Networks of Colorado Ambulatory Practices and Partners (SNOCAP)
2008
·
K. Voorhees
, D. H. Fernald
, et al.
·
The Journal of the American Board of Family Medicine
·
22
PDF
Gluten-induced Neurocognitive Impairment
2021
·
Jessica B. Edwards George
, Babatunde Aideyan
, et al.
·
Journal of Clinical Gastroenterology
·
18
Understanding the impact of long-chain fatty acid oxidation disorders for patients and caregivers
2022
·
Eliza Kruger
, Kristin Voorhees
, et al.
·
Molecular Genetics and Metabolism Reports
·
6
PDF
Self-Reported Dietary Adherence, Disease-Specific Symptoms, and Quality of Life are Associated with Healthcare Provider Follow-Up in Celiac Disease
2017
·
Jacob J. Hughey
, Bonnie K. Ray
, et al.
·
Gastroenterology
·
6
Physicians Caring for Celiac Patients do not Routinely Recommend Screening of First-Degree Family Members
2015
·
Abhik Roy
, Colin Smith
, et al.
·
Journal of Gastroenterology and Hepatology Research
·
3
PDF
Pcr24 Patient Descriptions of Improved Ability to Self-regulate Blood Sugar Levels in a Phase 3 Trial of Dtx401 for Glycogen Storage Disease Type Ia
2026
·
Diane M. Turner-Bowker
, Shayna Egan
, et al.
·
Value in Health
·
2
Pcr63 Patient Descriptions of the Benefits of a Reduced Cornstarch Dose Regimen in a Phase 3 Trial of Dtx401 for Glycogen Storage Disease Type Ia
2026
·
Diane M. Turner-Bowker
, Shayna Egan
, et al.
·
Value in Health
·
1
What is the impact of long-chain fatty acid oxidation disorders on everyday life? Plain language summary of a survey
2024
·
Christy Abrams
, Kristin Voorhees
, et al.
·
Future Rare Diseases
·
1
Global patient advocacy and health outcomes perspectives on the impacts of managing glycogen storage disease type Ia (GSDIa)
2026
·
A. Blake
, V. Buxton
, et al.
·
Molecular Genetics and Metabolism
Caregivers' perspectives of the MPS IIIA (Sanfilippo sydrome type A) diagnostic journey and ways to improve for future families
2026
·
Kristin Voorhees
, Joshua R. Call
, et al.
·
Molecular Genetics and Metabolism
P448: Burden of healthcare system navigation on people and families living with glycogen storage disease type Ia and their care team
2026
·
Elizabeth Dorn
, Malaya Mount
, et al.
·
Genetics in Medicine Open
PDF
PCR256 Unseen Burdens of Glycogen Storage Disease Type Ia (GSDIa) Experienced by Patients, Caregivers, and their Healthcare Team
2025
·
Manpreet K. Sidhu
, Ciara Harkins
, et al.
·
Value in Health
PRO47 Understanding the Burden of Long-Chain Fatty Acid Oxidation Disorders for Patients and Caregivers
2021
·
E. Kruger
, K. Voorhees
, et al.
·
Value in Health
PDF
Path to diagnosis and the caregiver’s perspective on the impact of creatine transporter deficiency
2021
·
Linda Rees
, Ayla Evins
, et al.
·
Molecular Genetics and Metabolism
Community Family Member Screening Event for Diagnosis of Celiac Disease
2017
·
Elizabeth Jensen
, Angie M. Almond
, et al.
·
The American Journal of Gastroenterology
Effects of Patient Education on Adherence and Quality of Life in Celiac Disease at a Tertiary Celiac Center
2017
·
Andrew H. Zabolotsky
, Piotr Sowa
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
19
Citation count:
204
H-index:
6
I10-index:
4
Year
Topic
Type